Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Jurnal Fisioterapi dan Rehabilitasi Jurnal Kesehatan
Marolop Parlindungan Napitu
Universitas Efarina
Health Professions Public Health Other

Published : 3 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : Jurnal Kesehatan

 1 
Tingkat Pengetahuan Masyarakat Dan Pengunjung Tentang Obat Swamedikasi Dan Rasionalitas Di Dua Apotek Kecamatan Bandar Kabupaten Simalungun Meyana Marbun; Shofian Syarifuddin; Wilson Samosir; Marolop Parlindungan Napitu; Muliati Muliati
Jurnal Kesehatan Vol. 8 No. 1 (2020): April : Health Journal “Love That Renewed”
Publisher : Sekolah Tinggi Ilmu Kesehatan Santo Borromeus

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55912/jks.v8i1.121

Abstract

Self-medication, as the most widely used effort to treat minor illnesses, is still constrained by limited public knowledge about drugs and their use. This study was conducted to analyze the effect of education using leaflet media on the level of knowledge and rationality of self-medication use. This pre-experimental study used a one group pre-test/post-test study design. Respondents were visitors aged 18-59 years at two pharmacies in the Bandar sub-district, who had used oral medication to treat fever, cough, flu, pain, diarrhea and gastritis in the three months before the time of the study. Respondents were taken by consecutive sampling. Data collection was carried out through guided free interviews using a questionnaire that had been tested for validity and reliability. Leaflets containing information about self-medication were given to respondents after the pre-test was carried out. The number of respondents obtained was as many as 97 respondents. All of these respondents were contacted again by telephone after 4-5 weeks of education, to do a post-test using the same questionnaire used during the pre-test. The Wilcoxon test and McNemar test were used to statistically analyze the data obtained. Based on the results of this study, it can be concluded that education can significantly increase self-medication knowledge (p = 0.000) and the rationality of respondents' self-medication use (p = 0.015).
Analisis Efektivitas Biaya Pengobatan Hipertensi Dan Diabetes Melitus Di Rumah Sakit Efarina Ataham Pangkalan Kerinci Meyana Marbun; Marolop Parlindungan Napitu; Hendri Kurniawan; Ismi Noer Fadilah; Muliti Muliti
Jurnal Kesehatan Vol. 9 No. 1 (2021): April : Health Journal “Love That Renewed”
Publisher : Sekolah Tinggi Ilmu Kesehatan Santo Borromeus

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55912/jks.v9i1.124

Abstract

Hypertension is a condition in which blood pressure increases above (≥140/90 mmHg). The prevalence in Indonesia is 32.2% and only 24.2% of these hypertensive patients are diagnosed and receiving treatment. Diabetes mellitus (DM) is a metabolic disorder characterized by glucose levels exceeding normal values or perglycemia (≥200 mg/dl). to evaluate the cost-effectiveness of antihypertensive and anti-diabetic in patients who are hospitalized at Efarina Etaham Berastagi Hospital, Karo. This research is non-experimental using data taken from patient medical records retrospectively for the period January-June 2017. The analytical method used is Cost Effectiveness Analysis (CEA). The Cost Effectiveness Average Ratio (CEA Ratio) and Incremental Cost Effectiveness Ratio (ICER) methods were used to analyze the most cost-effective antihypertensives and antidiabetics. The results of this study showed that the hypertension therapy regimens used were amlodipine, captropil, valsartan, amlodipine + captropil, amlodipine + valsartan, captorpil + valsartan, and amlodipine + captorpil + valsartan. In the anti-diabetic therapy regimen used are insulin analogues, metmorphine and insulin analogues + metmorphine. The most cost-effective antihypertensive based on the CEA and ICER is amdolpine + captropil and the most cost-effective diabetic liver based on the CEA and ICER is metmorphine.
Co-Authors Hendri Kurniawan Ismi Noer Fadilah Meyana Marbun Muliati Muliati Muliti Muliti Shofian Syarifuddin Wilson Samosir